Titan Pharmaceuticals Inc (TTNP)
6.71
+0.01
(+0.15%)
USD |
NASDAQ |
May 02, 16:00
6.71
0.00 (0.00%)
After-Hours: 16:00
Titan Pharmaceuticals Cash from Financing (Quarterly): 0.406M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.406M |
| September 30, 2023 | 9.594M |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.003M |
| March 31, 2022 | 4.981M |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 8.841M |
| December 31, 2020 | 5.91M |
| September 30, 2020 | 2.466M |
| June 30, 2020 | 1.50M |
| March 31, 2020 | 8.057M |
| December 31, 2019 | 8.077M |
| September 30, 2019 | 2.015M |
| June 30, 2019 | 0.571M |
| March 31, 2019 | 0.605M |
| December 31, 2018 | 4.521M |
| September 30, 2018 | 9.099M |
| June 30, 2018 | 0.00 |
| March 31, 2018 | -3.00M |
| December 31, 2017 | -0.283M |
| Date | Value |
|---|---|
| September 30, 2017 | 7.012M |
| June 30, 2017 | 0.00 |
| March 31, 2017 | |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.027M |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | -0.014M |
| December 31, 2014 | 9.592M |
| September 30, 2014 | 0.00 |
| June 30, 2014 | -0.037M |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 4.925M |
| September 30, 2013 | 0.00 |
| June 30, 2013 | -2.50M |
| March 31, 2013 | 1.388M |
| December 31, 2012 | 3.676M |
| September 30, 2012 | 3.468M |
| June 30, 2012 | 4.92M |
| March 31, 2012 | -0.044M |
| December 31, 2011 | 5.00M |
| September 30, 2011 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
Jun 2021
9.594M
Maximum
Sep 2023
2.759M
Average
0.571M
Median
Jun 2019
Cash from Financing (Quarterly) Benchmarks
| Outset Medical Inc | 33.23M |
| Allurion Technologies Inc | -20.41M |
| AIM ImmunoTech Inc | 0.147M |
| Protalix BioTherapeutics Inc | 0.00 |
| Armata Pharmaceuticals Inc | -0.043M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.246M |
| Cash from Investing (Quarterly) | 0.504M |
| Free Cash Flow | -7.092M |
| Free Cash Flow Per Share (Quarterly) | -2.972 |
| Free Cash Flow Yield | -140.5% |